Drug Combination Details

General Information of the Combination (ID: C88574)
Name Lactoferrin + Arabinogalactan + Rifaximin alpha
    Click to Show/Hide the Each NP or Drug Information of This Combination
Name Lactoferrin   NP Info     Drug Info 
Structure
Name Arabinogalactan   NP Info 
Structure
Disease
Diverticulosis [ICD-11: DC70]
Investigative [1]
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. Enhancing Drug Efficacy by This Combination
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Experiment 1 Reporting the Effect of This Combination [1]
                    In-vivo Model Retrospective observational survey study
                    Experimental
                    Result(s)		 Combination therapy with cyclic rifaximin-Alpha and continuous arabinogalactan combined with lactoferrin are effective in SUDD treatment in terms of symptom resolution, bowel movement normalization, prevention of recurrences with very good patient's compliance.
References
Reference 1 Combined therapy: rifaximin-Alpha and arabinogalactan with lactoferrin combination effectively prevents recurrences of symptomatic uncomplicated diverticular disease. Pol Przegl Chir. 2020 Apr 7;92(2):22-28.
 Download Picture         KEGG Link